Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
Pivotal role of choline metabolites in remyelination.
Natalizumab and monocytes in multiple sclerosis: The dim haze of mystery and the enchantment of pursuit.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity.
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss.
Blind analysis: Hide results to seek the truth.
Potential role of 8-oxoguanine DNA glycosylase 1 as a STAT1 coactivator in endotoxin-induced inflammatory response.
A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
Reviewing the role of Resveratrol as a natural modulator of microglial activities.
Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.
Dark microglia: A new phenotype predominantly associated with pathological states.
Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Pathophysiology of immune-mediated demyelinating neuropathies - Part I: Neuroscience.
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
The role of the community nurse in care provision for people with multiple sclerosis.
Most Scottish neurologists do not apply the 2010 McDonald criteria when diagnosing multiple sclerosis.
Pages
« first
‹ previous
…
422
423
424
425
426
427
428
429
430
…
next ›
last »